Headline: Zydus Lifesciences Limited Q2 FY26 Earnings Call Scheduled for November 6, 2025

Zydus Lifesciences Limited (BSE: 532321, NSE: Zyduslife) has announced the details for its upcoming earnings call following the release of its financial results for the second quarter of FY26, covering the period from July to September 2025. The results will be disclosed on November 6, 2025, with a live Q&A session set to commence at 4:00 PM IST.

Dr. Sharvil Patel, Managing Director of Zydus Lifesciences, will host the call, providing investors and analysts an opportunity to delve into the company's performance and strategic direction. Interested participants must pre-register to join the session. A registration link has been provided for convenience: [Pre-register here](https://bit.ly/432CKI6).

Following the earnings announcement, the presentation materials and an audio recording of the call will be accessible on Zydus’s Investor Zone webpage. This transparency aligns with the company's commitment to keeping stakeholders informed, in accordance with SEBI regulations.

For those looking to stay updated on Zydus Lifesciences' financial performance, the live call and subsequent materials will offer valuable insights into the company's trajectory and market strategies.

Stay tuned for the results and partake in the conversation to gain a deeper understanding of Zydus Lifesciences’ position in the dynamic pharmaceutical landscape.

For more information, visit: [Zydus Lifesciences Investor Zone](https://www.zyduslife.com/investorzone).

This blog post aims to keep investors informed and engaged with essential updates from Zydus Lifesciences Limited.